We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thales AVS France

Intelerad

Intelerad Medical Systems offers medical imaging PACS and cross-enterprise workflow solutions for imaging providers r... read more Featured Products: More products

Download Mobile App




Intelerad to Invest USD 75 Million in New AI Medical Imaging Offerings

By Medimaging International staff writers
Posted on 22 Jun 2019
Print article
Image: Intelerad has committed 75 million to R&D for new AI and cloud-based medical imaging software solutions (Photo courtesy of Intelerad).
Image: Intelerad has committed 75 million to R&D for new AI and cloud-based medical imaging software solutions (Photo courtesy of Intelerad).
Intelerad Medical Systems (Montreal, Canada), a medical imaging software provider that specializes in diagnostic viewing, reporting and collaboration solutions, has announced a USD 75 million R&D investment towards extending its solutions portfolio.

Intelerad’s technology simplifies everyday tasks for radiologists and other healthcare professionals, enabling them to optimize efficiency and apply their expertise and energy toward more personalized services and follow-ups for every patient. On a daily basis, Intelerad’s solutions enable radiologists to perform more than 200,000 diagnostic interpretations worldwide.

With an emphasis on cloud technology and artificial intelligence, Intelerad is focused on providing innovative Software as a Service (SaaS) solutions for healthcare. For example, the company’s cloud-based Clairvoyance productivity dashboard will incorporate machine learning technology to provide predictive insights to imaging departments, enabling real-time, data-driven decisions that contribute to higher quality, more timely care and better outcomes for patients. The company’s USD 75 million investment and ongoing focus on creating innovative, market-leading solutions for a global customer base are expected to fuel a two-fold increase in study volume.

“Medical imaging has undergone a significant transformation over the past 20 years, and Intelerad has been at the forefront of that evolution,” said Mr. Paul Lepage, President and CEO of Intelerad. “We are proud to support customers around the world in providing the highest standard of healthcare services. We will continue to make a difference in healthcare by delivering scalable, enterprise-wide medical imaging solutions for healthcare providers and their patients.”



Print article
Radcal
Clear Image Devices

Channels

Copyright © 2000-2019 Globetech Media. All rights reserved.